Hematology
Pacientes Actuales
Concierte una cita por teléfono
617.638.6428
Concierte una cita con MyChart
Reserva con MyChart
Nuevos Pacientes
Si es un paciente nuevo y necesita una cita, comuníquese con nosotros al número de teléfono a continuación.
Obtenga más información sobre una visita a BMC. 617.638.6428Recomendar a un Paciente
Recomendar a un paciente
Llame para obtener ayuda con el proceso de referencia
617.638.6428
Patients with blood disorders receive consultation and treatment for a broad range of benign conditions, such as hemoglobinopathies (sickle cell anemia and thalassemia), hemochromatosis, bleeding and thrombotic disorders (von Willebrand's disease and hemophilia), hypercoagulable states, myeloproliferative disorders, myelodysplasia and anemia, and malignancies such as leukemia, lymphoma and myeloma.
The team works closely with the blood bank and has developed innovative techniques for harvesting, storing, and re-infusing blood and its components, most notably for autologous peripheral blood stem cell infusion. Apheresis is also available for treatment of a variety of disorders including sickle cell disease, Waldenstrom's macroglobulinemia, and cryoglobulinemia.
The Infusion Suite is housed in the Center and provides patients with the utmost privacy, comfort, and convenience. The Suite includes private rooms with beds and bays with large reclining chairs for patients and comfortable seating for those who accompany them. Patient Navigators (experts trained to help patients overcome barriers to care), social workers, and dieticians are also located in the Infusion Suite and are available to help patients with any needs that arise during their visit. A specialty pharmacy is conveniently located on the floor, allowing patients to fill many of their medications without leaving the area.
Contáctenos
Clínicas Especializadas
Amyloidosis Center
Boston Medical Center is an international referral center for the diagnosis and treatment of amyloidosis, a rare group of diseases caused by the abnormal accumulation of the protein amyloid in various parts of the body. This can occur as part of a bone marrow plasma cell disorder (AL), as a hereditary form (AF), an age-related form (senile systemic amyloidosis due to ATTR), or secondary to chronic inflammatory or infectious diseases (AA).
Sickle Cell Disease
Condiciones que Tratamos
Nuestro Equipo
Lynsie Adams, NP
Special Interests
Hematología y Oncología
Linda M Armstrong, NP
Special Interests
Hematología
Frances R Blevins, PA-C
Special Interests
Hematología
Adam Lerner, MD
Special Interests
Linfoma, leucemia, sarcoma, cáncer de piel
Lillian E McMahon, MD
Special Interests
Hematología de células falciformes en adultos
Lisa M Mendelson, NP
Assistant Professor of Medicine, Boston University School of Medicine
John M Sloan, MD
Special Interests
AL Amiloidosis, Linfoma y Leucemia, Mieloma Múltiple, Trombosis y Hemostasia, Trasplante Autólogo de Células Madre
Martin H Steinberg, MD
Special Interests
Enfermedad de célula falciforme
Charlene M Sylvestre, NP
Special Interests
Hematología de células falciformes en adultos
Amyloidosis Team
John M Sloan, MD
Special Interests
AL Amiloidosis, Linfoma y Leucemia, Mieloma Múltiple, Trombosis y Hemostasia, Trasplante Autólogo de Células Madre
Lisa M Mendelson, NP
Assistant Professor of Medicine, Boston University School of Medicine
Tracy A Joshi, DNP
Special Interests
Amiloidosis, amiloidosis AL, amiloidosis por transtiretina, amiloidosis localizada
Benign Hematology Team
Lynsie Adams, NP
Special Interests
Hematología y Oncología
Linda M Armstrong, NP
Special Interests
Hematología
Frances R Blevins, PA-C
Special Interests
Hematología
Adam Lerner, MD
Special Interests
Linfoma, leucemia, sarcoma, cáncer de piel
Antoine-Jean Ribeil, MD, PHD
Special Interests
Hemoglobinopathies, Red Blood Cell Disorders
John M Sloan, MD
Special Interests
AL Amiloidosis, Linfoma y Leucemia, Mieloma Múltiple, Trombosis y Hemostasia, Trasplante Autólogo de Células Madre
Raphael E Szalat, MD, PHD
Special Interests
Myeloma, Monoclonal gammopathies, auto-immune cytopenia, lymphoma
Malignant Hematology Team
Lynsie Adams, NP
Special Interests
Hematología y Oncología
Linda M Armstrong, NP
Special Interests
Hematología
Frances R Blevins, PA-C
Special Interests
Hematología
Adam Lerner, MD
Special Interests
Linfoma, leucemia, sarcoma, cáncer de piel
John M Sloan, MD
Special Interests
AL Amiloidosis, Linfoma y Leucemia, Mieloma Múltiple, Trombosis y Hemostasia, Trasplante Autólogo de Células Madre
Raphael E Szalat, MD, PHD
Special Interests
Myeloma, Monoclonal gammopathies, auto-immune cytopenia, lymphoma
Sickle Cell Disease Team
Jean-Antoine Ribeil, MD, PhD: Clinical Director, Sickle Cell Center of Excellence; Associate Professor of Medicine
Lillian E McMahon, MD
Special Interests
Hematología de células falciformes en adultos
Charlene M Sylvestre, NP
Special Interests
Hematología de células falciformes en adultos
Stem Cell Transplant and Cellular Therapy Team
Recursos del Paciente
Preguntas frecuentes sobre hematología
Resumen de la Investigación
Clinical trials are research studies in which people help doctors find ways to improve health and health care.
They can help answer scientific questions and find better ways to prevent, diagnose, or treat cancer. Many of today's treatments for cancer are based on the results of past clinical trials. Because of progress made through clinical trials, many people treated for cancer now live longer, and some are even cured from their disease.
Patients who are interested in joining a research study, or who would like to see if there are any ongoing trials that might be appropriate for their condition, can talk to their doctor or nurse, or call the Clinical Trials Office directly at 617.638.8265 to speak with research nurses and assistants.
Clinical Trials
The Clinical Trials Office of the Cancer Research Center coordinates BMC’s participation in several national cancer cooperative trials, directed not only at new therapies but also at prevention, education, and screening for early detection. A key component is the team’s active participation in the Southwest Oncology Group (SWOG), a national clinical trials cooperative established with National Cancer Institute (NCI) funding. BMC is the only full-member institution in New England, and is also a member of NSBBP (National Surgical Breast and Bowel program). Participation in SWOG and NSBBP clinical trials affords access to many investigational drugs and protocols sponsored by the NCI that would be unavailable otherwise. In addition, the team comprises the principal investigators for a series of clinical trials at Boston Medical Center.
Learn more about ongoing trials. Physicians who are interested in referring a patient for possible inclusion in one of these trials, should contact the Clinical Trials Office directly at 617.638.8265.
Información Sobre Residencia y Becas
Hematology and Oncology Fellowship Program
The Hematology and Oncology fellowship program at Boston Medical Center is a combined teaching program with the Boston University School of Medicine and the Boston Veterans Administration Medical Center. The fellowship is an ACGME accredited three year program, and offers three separate tracks: Hematology and Oncology; Geriatric Oncology (with fourth year Hematology option); and Hematology research training. For more information, click here.
